Skip to main content
. 2018 Jun 28;2018:1029401. doi: 10.1155/2018/1029401

Table 2.

VZV, EBV, and CMV seroprevalence.

VZV (n = 129) EBV (n = 74) CMV (n = 80)
Seroprevalence 97.6% (n = 126) 86.5% (n = 64) 30% (n = 24) p = 0.00001
<60 years 98% (n = 109) 84% (n = 54) 25.75% (n = 17)
>60 years 94% (n = 17) 100% (n = 10) 50% (n = 7)